Home > Boards > US OTC > Biotechs > Hepion Pharmaceuticals, Inc (HEPA)

they priced that offering at $6 correct??

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
kingsransome Member Profile
 
Followed By 106
Posts 7,369
Boards Moderated 0
Alias Born 03/01/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/8/2021 4:31:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2021 4:25:14 PM
Hepion Pharmaceuticals to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference GlobeNewswire Inc. - 10/7/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2021 5:23:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 9:23:16 AM
All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431 GlobeNewswire Inc. - 9/29/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:29:53 AM
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program GlobeNewswire Inc. - 9/13/2021 8:00:00 AM
Hepion Pharmaceuticals Schedules Conference Call to Review Data from Phase 2a ‘AMBITION’ Clinical Trial of CRV431 in NASH GlobeNewswire Inc. - 9/10/2021 4:05:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/7/2021 6:00:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2021 9:20:13 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/23/2021 6:09:24 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 6:01:21 AM
Hepion Pharmaceuticals Announces Postponement of 2021 Annual Meeting of Stockholders GlobeNewswire Inc. - 7/23/2021 4:40:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2021 10:38:43 AM
Hepion shares fall after CRV431 mid-stage NASH study results Seeking Alpha - 7/13/2021 8:32:27 AM
Hepion Pharmaceuticals Announces Positive Topline Data from Phase 2a ‘AMBITION’ NASH Trial; All Primary Endpoints Achieve... GlobeNewswire Inc. - 7/13/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 4:47:31 PM
Hepion Pharmaceuticals Announces Adjournment of Annual Meeting GlobeNewswire Inc. - 6/25/2021 4:30:00 PM
Hepion Pharmaceuticals to join Russell Microcap Seeking Alpha - 6/9/2021 9:40:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 9:07:01 AM
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index GlobeNewswire Inc. - 6/9/2021 7:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 7:13:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:37:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:37:36 PM
kingsransome   Friday, 06/21/19 02:50:52 PM
Re: airahim post# 842
Post # of 1825 
they priced that offering at $6 correct??

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences